Plasma VEGF-A and its soluble receptor R1 correlate with the clinical stage of colorectal cancer.
Our aim was to assess plasma VEGF-A and its soluble receptor R1 (sVEGF-R1) in patients with colorectal cancer, in comparison with apparently healthy subjects. Samples of plasma were collected from 26 patients with colorectal cancer before surgery and on post-operative day 3 and 10, frozen and eventually assessed, using ELISA kits. We found an increase in VEGF-A in colorectal cancer patients and a strong positive correlation between metastatic spread and postoperative VEGF-A, which also correlated with CA19.9. Soluble VEGF-R1 showed a positive correlation with lymph node involvement. Our findings may suggest that the patients with high postoperative VEGF-A should be scanned for metastases. In view of our finding that sVEGFR-1 correlates with lymph node involvement, precautions must be taken in studies of sVEGFR-1 as a potential therapeutic agent.